{
    "Trade/Device Name(s)": [
        "INRatio/INRatio2 Test Strips",
        "INRatio/INRatio2 PT Monitoring System",
        "INRatio Test Strips",
        "INRatio2 System"
    ],
    "Submitter Information": "Biosite Incorporated, an Inverness Medical Innovations Company",
    "510(k) Number": "K092987",
    "Predicate Device Reference 510(k) Number(s)": [
        "K072727"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GJS"
    ],
    "Summary Letter Date": "June 11, 2010",
    "Summary Letter Received Date": "April 13, 2010",
    "Submission Date": "April 13, 2010",
    "Regulation Number(s)": [
        "21 CFR 864.7750"
    ],
    "Regulation Name(s)": [
        "Prothrombin Time Test"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Prothrombin Time (PT)"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "INRatio Monitor",
        "INRatio2 Monitor"
    ],
    "Method(s)/Technology(ies)": [
        "One-stage Prothrombin Time test",
        "Electrical impedance detection",
        "Recombinant human thromboplastin reagent"
    ],
    "Methodologies": [
        "Prothrombin Time measurement",
        "Impedance-based coagulation testing"
    ],
    "Submission Type(s)": [
        "Test Strip",
        "Monitoring System",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for INRatio/INRatio2 Test Strips for quantitative measurement of Prothrombin Time in fresh capillary whole blood using impedance-based coagulation testing.",
    "Indications for Use Summary": "For quantitative measurement of Prothrombin Time in fresh capillary whole blood, intended for professional and home use by patients on warfarin or other oral anticoagulant therapy to monitor blood clotting time.",
    "fda_folder": "Hematology"
}